Fact CheckerSign in

NCT06426173Recruiting

Effect of Resistance Training in Patients on the Waiting List for Heart Transplant

Effect of Resistance Training on Functional Capacity, Quality of Life and Cardiac Biomarkers in Patients on the Waiting List for Heart Transplant: a Randomized and Controlled Clinical Trial

Source: ClinicalTrials.gov · Last updated 22 Jun 2026

Brief summary (registry, in English)

The present longitudinal, randomized, and blinded clinical trial aims to: * Evaluate the effects of resistance training on the functional capacity, quality of life, and cardiac biomarkers of hospitalized patients with heart failure (HF) on the waiting list for heart transplantation (HTx). * Evaluate the associations between Fried's frailty classification and functional capacity responses to resistance training. The protocol will have a total duration of 12 weeks.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
29 Apr 2024
Start date
18 Jun 2024
Primary completion date
18 Mar 2025
Lead sponsor
University of Sao Paulo General Hospital
NCT number
NCT06426173

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 18 Jun 2024 to the primary completion date, 18 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • heart failure of arrhythmogenic and/or restrictive etiology
  • presence of uncontrolled acute arrhythmias

Other

  • cognitive, orthopedic, or neuromotor changes that prevent functional tests from being carried out

Who the study is looking for

  • patients included in heart transplant list ≤1 month
  • hemodynamically stable in the last 48 hours defined as mean arterial pressure (MAP) ≥ 60 mmHg and ≤ 120 mmHg and - Heart rate (HR) ≥ 60 bpm and ≤ 120 mmHg.
  • dobutamine dose ≤ 10 mcg/kg/min

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Coordinator of this site? Confirm its status
São PauloBrazilRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.